missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human CD30 Ligand/TNFSF8 ELISA Kit 
ELISA
Supplier: Invitrogen™ EH84RB
Description
Human CD30 Ligand/TNFSF8 quantitates human CD30 Ligand/TNFSF8 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CD30 Ligand/TNFSF8.
The ligand for CD30 is CD30L (CD153). The binding of CD30 to CD30L mediates pleiotropic effects including cell proliferation, activation, differentiation, and apoptotic cell death. CD30 has a critical role in the pathophysiology of Hodgkin's disease and other CD30+ lymphomas. CD30 acts as a costimulatory molecule in thymic negative selection. In addition to its expression on Hodgkin's and Reed-Sternberg cells, CD30 is also found in some non-Hodgkin's lymphomas (including Burkitt's lymphomas), virus-infected T and B cells, and on normal T and B cells after activation. In T cells, CD30 expression is present on a subset of T cells that produce Th2-type cytokines and on CD4+/CD8+ thymocytes that coexpress CD45RO and the IL4 receptor.Specifications
| CD153; CD153 antigen; CD30 antigen ligand; CD30 ligand; Cd30l; CD30-L; CD30LG; CD30ligand; Tnfsf8; TNLG3A; tumor necrosis factor (ligand) superfamily member 8; tumor necrosis factor (ligand) superfamily, member 8; tumor necrosis factor ligand 3 A; tumor necrosis factor ligand superfamily member 8; tumor necrosis factor superfamily member 8 | |
| 0.12 ng/mL | |
| ELISA | |
| Colorimetric Microplate Reader | |
| Tnfsf8 | |
| <10 | |
| HRP | |
| RUO | |
| 2°C to 8°C | |
| 1 hrs 20 mins |
| 0.123 to 30 ng/mL | |
| HRP | |
| Plasma, Serum, Supernatant | |
| 944 | |
| <12% | |
| Pre-coated 96 well plate, Standard, Assay Diluent concentrate, Biotinylated Detection Antibody, SAV-HRP, Wash Buffer, Chromogen, Stop Solution, Adhesive Plate Covers | |
| 96 Tests | |
| Plasma 50 μL, Serum 50 μL, Supernatant 50 μL | |
| CD153 | |
| 4 hrs 45 mins |